UiPath Inc.

NYSE:PATH

11.59 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q1
Revenue 423.646354.653316.253335.112405.253325.921287.31289.588308.549262.744242.222245.066289.698220.816195.521186.217207.875147.289139.376113.103
Cost of Revenue 64.53463.76363.3255.91654.0749.9248.98743.66747.69142.76844.57645.01641.16443.135.59449.0120.13617.38514.69813.638
Gross Profit 359.112290.89252.933279.196351.183276.001238.323245.921260.858219.976197.646200.05248.534177.716159.927137.207187.739129.904124.67899.465
Gross Profit Ratio 0.8480.820.80.8330.8670.8470.8290.8490.8450.8370.8160.8160.8580.8050.8180.7370.9030.8820.8950.879
Reseach & Development Expenses 99.6796.97698.43385.60385.63984.51486.60675.34281.8767.34167.84968.6964.41261.55957.64693.0429.19427.45626.54126.729
General & Administrative Expenses 48.99750.0963.51963.5159.45256.02459.57756.58450.37563.15768.44357.5360.24459.49855.83474.41544.57465.95124.83426.676
Selling & Marketing Expenses 176.836187.188194.33180.139191.717191.282169.725160.406173.76156.469181.547189.782174.757172.906144.268205.75199.3899.51290.33190.931
SG&A 225.833237.278257.849243.058250.454247.306229.302216.99224.135219.626249.99247.312235.001232.404200.102280.166143.954165.463115.165117.607
Other Expenses 00010.6796.28413.7257.4724.29400.888-0.6-2.811-4.745-4.3-1.225-3.2184.643-6.30324.01-7.837
Operating Expenses 325.503334.254356.282328.661336.093331.82315.908292.332306.005286.967317.839316.002299.413293.963257.748373.206173.148192.919141.706144.336
Operating Income 33.609-43.364-103.349-49.46515.09-55.819-77.585-46.411-45.147-66.991-120.193-115.952-50.879-116.247-97.821-235.99914.591-63.015-17.028-44.871
Operating Income Ratio 0.079-0.122-0.327-0.1480.037-0.171-0.27-0.16-0.146-0.255-0.496-0.473-0.176-0.526-0.5-1.2670.07-0.428-0.122-0.397
Total Other Income Expenses Net 21.01517.86521.0824.50921.50128.20821.05418.14218.18810.4493.905-1.82-3.8-3.401-0.459-2.2775.044-6.15924.087-7.307
Income Before Tax 54.624-25.499-82.269-24.95636.596-27.611-56.531-28.269-26.959-56.542-116.288-117.772-54.679-119.648-98.28-238.27619.635-69.1747.059-52.178
Income Before Tax Ratio 0.129-0.072-0.26-0.0740.09-0.085-0.197-0.098-0.087-0.215-0.48-0.481-0.189-0.542-0.503-1.280.094-0.470.051-0.461
Income Tax Expense 2.83-14.8443.8283.782.683.9263.833.6320.731.1824.094.7898.4313.1391.7461.387-6.6211.6222.0720.662
Net Income 51.794-10.655-86.097-28.73633.916-31.537-60.361-31.901-27.689-57.724-120.378-122.561-63.11-122.787-100.026-239.66326.256-70.7964.987-52.84
Net Income Ratio 0.122-0.03-0.272-0.0860.084-0.097-0.21-0.11-0.09-0.22-0.497-0.5-0.218-0.556-0.512-1.2870.126-0.4810.036-0.467
EPS 0.090.2-0.15-0.050.06-0.056-0.11-0.057-0.05-0.1-0.22-0.23-0.12-0.23-0.19-1.110.12-0.140.01-0.11
EPS Diluted 0.090.2-0.15-0.050.058-0.056-0.11-0.057-0.05-0.1-0.22-0.23-0.12-0.23-0.19-1.110.12-0.140.01-0.11
EBITDA 33.609-38.83-98.768-44.56318.932-50.399-70.324-39.906-36.297-58.105-110.424-109.154-47.809-110.083-92.181-231.09317.143-60.296-14.211-42.024
EBITDA Ratio 0.079-0.109-0.312-0.1330.047-0.155-0.245-0.138-0.118-0.221-0.456-0.445-0.165-0.499-0.471-1.2410.082-0.409-0.102-0.372